CVRX(CVRx, Inc.) 的财务报表:医疗保健,医疗器械。数据来自 SEC 公开申报与市场行情,不构成投资建议。
| 科目 | FY 截至 2021-12-31 | FY 截至 2022-12-31 | FY 截至 2023-12-31 | FY 截至 2024-12-31 | FY 截至 2025-12-31 |
|---|---|---|---|---|---|
| 营业收入 | $13.04M | $22.47M | $39.30M | $51.29M | $56.65M |
| 毛利润 | $9.40M | $17.47M | $33.04M | $42.96M | $48.34M |
| 营业利润 | −$25.97M | −$42.53M | −$43.10M | −$59.49M | −$51.27M |
| 净利润 | −$43.08M | −$41.43M | −$41.20M | −$59.97M | −$53.31M |
| 经营现金流 | −$27.73M | −$42.68M | −$39.02M | −$39.14M | −$40.17M |
| 自由现金流 | −$28.91M | −$43.36M | −$39.61M | −$40.51M | −$40.75M |
| 摊薄每股收益 | $-4.16 | $-2.02 | $-1.99 | $-2.65 | $-2.04 |